The Canadian government signs an agreement with AstraZeneca to procure 100,000 doses of the Evushield COVID-19 antibody therapy for use in high-risk patients. (CTV News) COVID-19 pandemic in Canada, COVID-19 drug developmentCOVID-19 pandemic link embed save